WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003006015) SUBSTITUTED THIAZOLES AND OXAZOLES AS CORTICOTROPIN RELEASING HORMONE LIGANDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/006015    International Application No.:    PCT/US2002/021885
Publication Date: 23.01.2003 International Filing Date: 10.07.2002
Chapter 2 Demand Filed:    12.02.2003    
IPC:
C07D 263/32 (2006.01), C07D 277/22 (2006.01), C07D 277/24 (2006.01), C07D 277/26 (2006.01), C07D 277/28 (2006.01), C07D 277/30 (2006.01), C07D 417/04 (2006.01), C07D 417/08 (2006.01), C07D 417/10 (2006.01)
Applicants: BRISTOL-MYERS SQUIBB PHARMA COMPANY [US/US]; Patent Department P.O. Box 4000 Princeton, NJ 08543-4000 (US)
Inventors: TERMIN, Andreas; (US).
GROOTENHUIS, Peter; (US).
WILSON, Dean; (US).
MOLTENI, Valentina; (US).
MAO, Long; (US)
Agent: GODDARD, Christine; Patent Department P.O. Box 4000 Princeton, NJ 08543-4000 (US).
MILLER, Suzanne E.; VALLA, S.Maurice; Woodcock Washburn LLP One Liberty Place -46th Floor Philadelphia, Pennsylvania 19103 United State of America (US)
Priority Data:
60/305,067 13.07.2001 US
Title (EN) SUBSTITUTED THIAZOLES AND OXAZOLES AS CORTICOTROPIN RELEASING HORMONE LIGANDS
(FR) THIAZOLES ET OXAZOLES SUBSTITUTES UTILISES COMME LIGANDS HORMONAUX DE LIBERATION DE LA CORTICOTROPHINE
Abstract: front page image
(EN)Provided herein are novel substituted thiazoles and oxazoles of the Formula (I):[Insert Formula (I)]as well as compositions, including pharmaceutical compositions, containing the same, and the use thereof in the treatment of various neurological and psychological disorders, e.g., affective disorder, anxiety and depression, treatable by antagonizing CRF receptors.
(FR)L'invention concerne de nouveaux thiazoles et oxazoles représentés par la formule (I), ainsi que des compositions, notamment des compositions pharmaceutiques contenant ces composés, et leur utilisation dans le traitement de divers troubles neurologiques et psychologiques tels que les troubles affectifs, l'anxiété et la dépression, qui peuvent être traités par des récepteurs CRF antagonisants.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)